European heart journal
Journal
Overview
publication venue for
-
Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-Regurgitation study.
2025
-
The SWEDEGRAFT trial: when absence of evidence is not evidence of absence.
2025
-
Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
2024
-
Great debate: myocardial infarction after cardiac surgery must be redefined.
2024
-
Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.
2024
-
Beyond the classic major cardiovascular event outcome for cardiovascular trials.
2024
-
Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
2024
-
Transcatheter heart valve explant with infective endocarditis-associated prosthesis failure and outcomes: the EXPLANT-TAVR international registry.
2024
-
Coronary Angiography and Bypass Surgery: born together and now going separate ways?
2024
-
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial..
44.
2023
-
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints..
44.
2023
-
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
2023
-
A2AR-mediated lymphangiogenesis via VEGFR2 signaling prevents salt-sensitive hypertension..
44.
2023
-
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance..
44.
2023
-
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients..
44.
2023
-
Radial artery vs. internal thoracic artery or saphenous vein grafts: 15-year results of the RAPCO trials.
2023
-
Iron Deficiency in Pulmonary Vascular Disease: Pathophysiological and Clinical Implications.
2023
-
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial..
44.
2023
-
Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial..
43.
2022
-
Post-operative atrial fibrillation and risk of heart failure hospitalization..
43.
2022
-
Left main revascularization: an evidence-based reconciliation..
43.
2022
-
Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study..
43.
2022
-
Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial..
43.
2022
-
Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study..
43.
2022
-
Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data..
43.
2021
-
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study..
42.
2021
-
Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice..
42.
2021
-
Mammographic features are associated with cardiometabolic disease risk and mortality..
42.
2021
-
Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
2021
-
Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)..
42.
2021
-
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)..
42.
2021
-
Taking a stand against air pollution - the impact on cardiovascular disease..
42.
2021
-
The win ratio approach for composite endpoints: practical guidance based on previous experience..
41.
2020
-
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial..
41.
2020
-
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis..
41.
2020
-
Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries..
41.
2020
-
Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry..
41.
2020
-
Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry..
41.
2020
-
Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14..
40.
2019
-
Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index..
40.
2019
-
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial..
40.
2019
-
Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial..
40.
2019
-
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial..
40.
2019
-
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial..
40.
2019
-
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?.
40.
2019
-
Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry..
40.
2019
-
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification..
40.
2019
-
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial..
39.
2018
-
An update on the journey towards precision medicine in cardiology..
39.
2018
-
Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study..
39.
2018
-
Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial..
39.
2018
-
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups..
39.
2018
-
The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin..
39.
2018
-
Staging classification of aortic stenosis based on the extent of cardiac damage..
38.
2017
-
BDNFVal66met polymorphism: a potential bridge between depression and thrombosis..
38.
2017
-
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial..
38.
2017
-
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX..
37.
2015
-
Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS)..
36.
2015
-
Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction..
36.
2015
-
Sustainable Development Goals and the future of cardiovascular health. A statement from the Global Cardiovascular Disease Taskforce..
35.
2014
-
Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors..
35.
2014
-
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial..
35.
2014
-
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial..
35.
2014
-
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation..
35.
2014
-
High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression..
35.
2013
-
Cardiologists urged to reduce inappropriate radiation exposure..
34.
2013
-
Hypertensive target organ damage predicts incident diabetes mellitus..
34.
2013
-
Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting..
34.
2013
-
Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial..
34.
2013
-
Phosphate: a novel cardiovascular risk factor..
34.
2012
-
Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit..
33.
2012
-
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke)..
33.
2012
-
The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study..
33.
2012
-
Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea..
33.
2012
-
Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes..
33.
2012
-
High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial..
33.
2011
-
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial..
32.
2011
-
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes..
32.
2011
-
All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy..
31.
2010
-
Towards a new order in cardiovascular medicine: re-engineering through global collaboration..
31.
2010
-
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study..
30.
2009
-
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes..
30.
2009
-
Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy..
29.
2008
-
Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure..
29.
2008
-
Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study..
29.
2008
-
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study..
28.
2007
-
Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study..
26.
2004
-
Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate?.
26.
2004
-
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes..
25.
2004
-
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?.
24.
2003
-
Predictors of 90-day outcome in patients stabilized after acute coronary syndromes..
24.
2003
-
Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial..
23.
2002
-
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker..
23.
2002
-
Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)..
21.
2000
-
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT..
21.
2000
-
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study..
20.
1999
-
Platelet alpha 2 adrenoceptor characteristics during the morning increase in platelet aggregability..
13.
1992
-
Adrenergic nervous system and left ventricular mass in primary hypertension..
10.
1989
-
Beneficial effects of diltiazem combined with beta blockade in angina pectoris..
6.
1985
-
Beneficial effect of adding nifedipine to beta-adrenergic blocking therapy in angina pectoris..
3.
1982
-
Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris..
1.
1980
-
Quality versus Quantity in Cardiothoracic Imaging: Limitations of the Relative Value Unit (RVU)..
40.
2019
-
A double blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days..
29.
2007
-
Relationship between blood pressure and blood viscosity..
14.
1993
-
Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction.
2019
-
Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC.
2024
-
The conundrum of the treatment for left main coronary disease..
41.
2020
-
Cancer cachexia: getting to the heart of the matter..
40.
2019
-
Road mapping ATLAS ACS 2: are we there yet?.
33.
2012
-
Tissue Doppler imaging for the pre-clinical diagnosis of cardiomyopathy..
25.
2004
-
Early invasive strategy for acute coronary syndromes without persistent ST-segment elevation: has the time come for 'drive-through' angiography?.
23.
2002
-
What have we learned from the recent large trials in acute coronary syndromes without ST-segment elevation?.
21.
2000
-
Improved outlook for patients with acute myocardial infarction: an interim progress report..
19.
1998
-
Progress in exercise electrocardiography..
17.
1996
-
Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging.
2019
-
Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization.
2017
-
Central blood pressure: current evidence and clinical importance.
2014
-
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
2007
-
Left main coronary disease: evolving management concepts.
2022
-
Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials.
2021
-
Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
2020
-
Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
2020
-
Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials.
2017
-
The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?
2015
-
Review of surgical prosthetic paravalvular leaks: diagnosis and catheter-based closure.
2012
-
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes.
2007
-
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
2007
-
Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes.
2006
-
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy.
2002
-
Description of patients undergoing high risk angioplasty. Analyses of various databases.
1995
-
Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor.
1995
-
Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease.
1993
-
Measurement of cardiac output by M-mode and two-dimensional echocardiography: application to patients with hypertension.
1990
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)